Key statistics
As of last trade, Syndax Pharmaceuticals Inc (1T3:DUS) traded at 16.50, 58.65% above the 52 week low of 10.40 set on Oct 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.70 |
---|---|
High | 16.70 |
Low | 16.50 |
Bid | 16.40 |
Offer | 16.70 |
Previous close | 17.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 85.10m |
Free float | 83.53m |
P/E (TTM) | -- |
Market cap | 1.60bn USD |
EPS (TTM) | -3.38 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 18:30 BST.
More ▼
Press releases
- Foundation Medicine Partners with Syndax to Develop a Companion Diagnostic in Hematology and Support Efforts to Pursue Regulatory Approval for an Assay Based on the FoundationOne®Heme Platform
- Incyte and Syndax Announce U.S. FDA Approval of Niktimvo™ (axatilimab-csfr) for the Treatment of Chronic Graft-Versus-Host Disease (GVHD)